This is a news story, published by The Atlantic, that relates primarily to Lykos Therapeutics news.
For more Lykos Therapeutics news, you can click here:
more Lykos Therapeutics newsFor more mental health treatments news, you can click here:
more mental health treatments newsFor more news from The Atlantic, you can click here:
more news from The AtlanticOtherweb, Inc is a public benefit corporation, dedicated to improving the quality of news people consume. We are non-partisan, junk-free, and ad-free. We use artificial intelligence (AI) to remove junk from your news feed, and allow you to select the best health news, business news, entertainment news, and much more. If you like mental health treatments news, you might also like this article about
psychedelic therapy. We are dedicated to bringing you the highest-quality news, junk-free and ad-free, about your favorite topics. Please come every day to read the latest psychedelic drug news, psychedelic drugs news, mental health treatments news, and other high-quality news about any topic that interests you. We are working hard to create the best news aggregator on the web, and to put you in control of your news feed - whether you choose to read the latest news through our website, our news app, or our daily newsletter - all free!
psychedelic medicineThe Atlantic
•
83% Informative
The FDA declined to approve MDMA -assisted therapy for PTSD , instead asking the drugmaker Lykos Therapeutics to conduct another clinical trial to better show that the treatment is safe and effective.
The FDA ’s decision, its first on a psychedelic drug, will likely only delay psychedelic medicine’s official debut in mainstream medicine.
Some experts worry that approval might hinge on dropping the therapy component, turning psychedelics into just more pills to pop.
Lykos ’s approach to therapy isn’t the only option in psychedelic medicine.
A good relationship with a therapist might be all that matters for good outcomes, instead of the precise form of therapy.
Many companies with psychedelic drugs in the regulatory pipeline are trying to minimize therapy as much as possible.
VR Score
81
Informative language
78
Neutral language
65
Article tone
informal
Language
English
Language complexity
66
Offensive language
possibly offensive
Hate speech
not hateful
Attention-grabbing headline
not detected
Known propaganda techniques
not detected
Time-value
long-living
External references
11
Source diversity
9
Affiliate links
no affiliate links